Du T. Loots

Dr. Du T. Loots

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2007 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
DLDu T. Loots
Du T. Loots
FWFrancois H. van der Westhuizen
Francois H. van der Westhuizen
LBLisa Botes
Lisa Botes

21 March 2007 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
LDLisa Davis
Lisa Davis
WSWelma Stonehouse
Welma Stonehouse
DLDu T. Loots
Du T. Loots
JMJanine Mukuddem-Petersen
Janine Mukuddem-Petersen
FWFrancois H. van der Westhuizen
Francois H. van der Westhuizen
JJJohann C. Jerling
Johann C. Jerling


12 March 2018 in Metabolomics
Verified
Journal Article
Closed access
PDF file
LVLeonie Venter
Leonie Venter
DLDu T. Loots
Du T. Loots
LMLodewyk Japie Mienie
Lodewyk Japie Mienie
PRPeet J. Jansen van Rensburg
Peet J. Jansen van Rensburg
SMShayne Mason
Shayne Mason
ZLZander Lindeque
Zander Lindeque

1 January 2009 in Methods and Findings in Experimental and Clinical Pharmacology
Verified
Journal Article
Closed access
MIM.S. Islam
M.S. Islam
DLDu T. Loots
Du T. Loots

1 January 2008 in Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
NCNamukolo Covic
Namukolo Covic
FWFrancois H. van der Westhuizen
Francois H. van der Westhuizen
CNChandrasekaran Nagaswami
Chandrasekaran Nagaswami
YBYelena Baras
Yelena Baras
DLDu T. Loots
Du T. Loots
MPMarlien Pieters
Marlien Pieters
Diabetic subjects have been shown to have altered fibrin network structures. One proposed mechanism for this is non-enzymatic glycation of fibrinogen due to high blood glucose. We investigated whether glycaemic control would result in altered fibrin network structures due to decreased fibrinogen glycation. Twenty uncontrolled type 2 diabetic subjects were treated with insulin in order to achieve glycaemic control. Twenty age- and body mass index (BMI)-matched non-diabetic subjects were included as a reference group. Purified fibrinogen, isolated from plasma samples was used for analysis. There was a significant decrease in fibrinogen glycation (6.81 to 5.02 mol glucose/mol fibrinogen) with a corresponding decrease in rate of lateral aggregation (5.86 to 4.62) and increased permeability (2.45 to 2.85 × 10−8 cm2) and lysis rate (3.08 to 3.27 μm/min) in the diabetic subjects after glycaemic control. These variables correlated with markers of glycaemic control. Fibrin clots of non-diabetic subjects had a significantly higher ratio of inelastic to elastic deformation than the diabetic subjects (0.10 vs. 0.09). Although there was no difference in median fiber diameter between diabetic and non-diabetic subjects, there was a small increase in the proportion of thicker fibers in the diabetic samples after glycaemic control. Results from SDS-PAGE indicated no detectable difference in factor XIIIa-crosslinking of fibrin clots between uncontrolled and controlled diabetic samples. Diabetic subjects may have altered fibrin network formation kinetics which contributes to decreased pore size and lysis rate of fibrin clots. Achievement of glycaemic control and decreased fibrinogen glycation level improves permeability and lysis rates in a purified fibrinogen model